Cited by 339Schizophrenia research and treatmentBipolar Disorder and TreatmentNeuroscience and Neuropharmacology Research

Differential Hippocampal Expression of Glutamic Acid Decarboxylase 65 and 67 Messenger RNA in Bipolar Disorder and Schizophrenia

Heckers, Stephan, Stone, David, Walsh, John, Shick, John, Koul, Pamposh, Benes, Francine M.·2002·Archives of General Psychiatry

Abstract

BACKGROUND: Expression of messenger RNA (mRNA) for the gamma-aminobutyric acid (GABA)-synthesizing enzyme, glutamic acid decarboxylase (GAD), in the prefrontal cortex and the number of GABAergic neurons in the hippocampus are reduced in schizophrenia and bipolar disorder. We tested the hypothesis that the expression of the 2 isoforms, one 65 kd (GAD(65)) and the other 67 kd (GAD(67)), is differentially affected in the hippocampus in schizophrenia and bipolar disorder. METHODS: Hippocampal sections from 15 subjects in 3 groups (control subjects and subjects with schizophrenia and bipolar disorder) were studied using an in situ hybridization protocol with sulfur 35-labeled complementary riboprobes for GAD(65) and GAD(67) mRNA. Emulsion-dipped slides were analyzed for the density of GAD mRNA-positive neurons in 4 sectors of the hippocampus and for the cellular expression level of both GAD mRNAs. RESULTS: The density of GAD(65) and GAD(67) mRNA-positive neurons was decreased by 45% and 43%, respectively, in subjects with bipolar disorder, but only 14% and 4%, respectively, in subjects with schizophrenia. The decreased density of GAD(65) mRNA-positive neurons in subjects with bipolar disorder was significant in sectors CA2/3 and dentate gyrus, and that of GAD(67) mRNA-positive neurons was significant in CA4, but not other hippocampal sectors. Cellular GAD(65) mRNA expression was significantly decreased in subjects with bipolar disorder, particularly in CA4, but not in schizophrenic subjects. Cellular GAD(67) mRNA expression was normal in both groups. CONCLUSION: We have found a region-specific deficit of GAD(65) and GAD(67) mRNA expression in bipolar disorder.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.59.6.521

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The high frequency of interneuron pathologies in the hippocampus and adjacent cortical areas, such as in schizophrenia and bipolar disorder, may partly reflect extended developmental vulnerability.

    “The preponderance of interneuron pathologies in the hippocampus and adjacent cortical areas, such as the interneuron pathologies observed in schizophrenia and BPD, might be, at least in part, a reflection of this extended developmental vulnerability [1, 9, 122, 140-142].”

    From Parvalbumin interneuron vulnerability and brain disorders (2021) · cites this paper as [142]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Heckers, S., Stone, D., Walsh, J., Shick, J., Koul, P., & Benes, F. M.
Affiliations
McLean Hospital (US)
Corresponding author
Benes, Francine M.
Venue
Archives of General Psychiatry
Published
2002-06-01
Volume
59
Issue
6
Pages
521
ISSN
0003-990X (ISSN-L)
OpenAlex
W2016712906
Cited by
322
References
35
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 8 · 2021: 31 · 2020: 9 · 2019: 9 · 2018: 7 · 2017: 8 · 2016: 11 · 2015: 8 · 2014: 16 · 2013: 19 · 2012: 17
FWCI
11.78
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of General Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1k23mh001763-01)
  • National Institute of Mental Health (MH.NS 31862, MH-42261, MH00423, MH31152, MH01763-02)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
GAD65, glutamic acid decarboxylase 67, hippocampus, bipolar disorder, schizophrenia, GABAergic neurons, CA4, dentate gyrus, CA2/3
MeSH terms
Adult, Aged, Bipolar Disorder, Diagnosis, Differential, Female, Glutamate Decarboxylase, Hippocampus, Humans, Isoenzymes, Male, Middle Aged, Neurons, Peptide Fragments, RNA, Messenger, Schizophrenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review